RE:stockman, obviously you are right, big reward$ will only So, Newcamo,err, Realstocky, you're agreeing with Stockman that it's dropping to $11US from $18 right now. What happened to $50-100 this year? Who are the execution managers at Liminal? Galbraith CEO who just delayed Ryplazim to Q3 and has done nothing with 4050 for a Phase1 trial of something they already had in several Phase 2 trials completely? They're executing on spending our money but not deliver tangible results, Realstocky!